99 related articles for article (PubMed ID: 16857728)
21. N-chlorination of sulfamethoxazole and dapsone by the myeloperoxidase system.
Uetrecht JP; Shear NH; Zahid N
Drug Metab Dispos; 1993; 21(5):830-4. PubMed ID: 7902244
[TBL] [Abstract][Full Text] [Related]
22. Is hydroxylamine-induced cytotoxicity a valid marker for hypersensitivity reactions to sulfamethoxazole in human immunodeficiency virus-infected individuals?
Reilly TP; MacArthur RD; Farrough MJ; Crane LR; Woster PM; Svensson CK
J Pharmacol Exp Ther; 1999 Dec; 291(3):1356-64. PubMed ID: 10565861
[TBL] [Abstract][Full Text] [Related]
23. Covalent binding of the nitroso metabolite of sulfamethoxazole is important in induction of drug-specific T-cell responses in vivo.
Cheng L; Stewart BJ; You Q; Petersen DR; Ware JA; Piccotti JR; Kawabata TT; Ju C
Mol Pharmacol; 2008 Jun; 73(6):1769-75. PubMed ID: 18334600
[TBL] [Abstract][Full Text] [Related]
24. Reactive oxygen species promotes cellular senescence in normal human epidermal keratinocytes through epigenetic regulation of p16(INK4a.).
Sasaki M; Kajiya H; Ozeki S; Okabe K; Ikebe T
Biochem Biophys Res Commun; 2014 Sep; 452(3):622-8. PubMed ID: 25181340
[TBL] [Abstract][Full Text] [Related]
25. High calcium, ATP, and poly(I:C) augment the immune response to β-glucan in normal human epidermal keratinocytes.
Hau CS; Tada Y; Shibata S; Uratsuji H; Asano Y; Sugaya M; Kadono T; Kanda N; Watanabe S; Tamaki K; Sato S
J Invest Dermatol; 2011 Nov; 131(11):2255-62. PubMed ID: 21796149
[TBL] [Abstract][Full Text] [Related]
26. Cytochrome P450-dependent toxicity of dapsone in human erythrocytes.
Ganesan S; Sahu R; Walker LA; Tekwani BL
J Appl Toxicol; 2010 Apr; 30(3):271-5. PubMed ID: 19998329
[TBL] [Abstract][Full Text] [Related]
27. An in vitro approach to detect metabolite toxicity due to CYP3A4-dependent bioactivation of xenobiotics.
Vignati L; Turlizzi E; Monaci S; Grossi P; Kanter Rd; Monshouwer M
Toxicology; 2005 Dec; 216(2-3):154-67. PubMed ID: 16169652
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the in vitro cytotoxicity of hydroxylamine metabolites of sulfamethoxazole and dapsone.
Reilly TP; Bellevue FH; Woster PM; Svensson CK
Biochem Pharmacol; 1998 Mar; 55(6):803-10. PubMed ID: 9586952
[TBL] [Abstract][Full Text] [Related]
29. Influence of reduced glutathione on the proliferative response of sulfamethoxazole-specific and sulfamethoxazole-metabolite-specific human CD4+ T-cells.
Burkhart C; von Greyerz S; Depta JP; Naisbitt DJ; Britschgi M; Park KB; Pichler WJ
Br J Pharmacol; 2001 Feb; 132(3):623-30. PubMed ID: 11159714
[TBL] [Abstract][Full Text] [Related]
30. Cytochrome P450 3A4 and CYP3A5-Catalyzed Bioactivation of Lapatinib.
Towles JK; Clark RN; Wahlin MD; Uttamsingh V; Rettie AE; Jackson KD
Drug Metab Dispos; 2016 Oct; 44(10):1584-97. PubMed ID: 27450182
[TBL] [Abstract][Full Text] [Related]
31. Cytochrome p450 architecture and cysteine nucleophile placement impact raloxifene-mediated mechanism-based inactivation.
VandenBrink BM; Davis JA; Pearson JT; Foti RS; Wienkers LC; Rock DA
Mol Pharmacol; 2012 Nov; 82(5):835-42. PubMed ID: 22859722
[TBL] [Abstract][Full Text] [Related]
32. Inhibition by atovaquone of CYP2C9-mediated sulphamethoxazole hydroxylamine formation.
Miller JL; Trepanier LA
Eur J Clin Pharmacol; 2002 Apr; 58(1):69-72. PubMed ID: 11956677
[TBL] [Abstract][Full Text] [Related]
33. "Danger" conditions increase sulfamethoxazole-protein adduct formation in human antigen-presenting cells.
Lavergne SN; Wang H; Callan HE; Park BK; Naisbitt DJ
J Pharmacol Exp Ther; 2009 Nov; 331(2):372-81. PubMed ID: 19666748
[TBL] [Abstract][Full Text] [Related]
34. Identification of the human cytochrome P450 enzymes involved in the in vitro biotransformation of lynestrenol and norethindrone.
Korhonen T; Turpeinen M; Tolonen A; Laine K; Pelkonen O
J Steroid Biochem Mol Biol; 2008 May; 110(1-2):56-66. PubMed ID: 18356043
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of atypical cytochrome P450 kinetics with two-substrate models: evidence that multiple substrates can simultaneously bind to cytochrome P450 active sites.
Korzekwa KR; Krishnamachary N; Shou M; Ogai A; Parise RA; Rettie AE; Gonzalez FJ; Tracy TS
Biochemistry; 1998 Mar; 37(12):4137-47. PubMed ID: 9521735
[TBL] [Abstract][Full Text] [Related]
36. Expression of multiple cytochrome p450 enzymes and multidrug resistance-associated transport proteins in human skin keratinocytes.
Baron JM; Höller D; Schiffer R; Frankenberg S; Neis M; Merk HF; Jugert FK
J Invest Dermatol; 2001 Apr; 116(4):541-8. PubMed ID: 11286621
[TBL] [Abstract][Full Text] [Related]
37. Proteomic analysis of the cellular response to a potent sensitiser unveils the dynamics of haptenation in living cells.
Parkinson E; Aleksic M; Kukic P; Bailey A; Cubberley R; Skipp P
Toxicology; 2020 Dec; 445():152603. PubMed ID: 32991956
[TBL] [Abstract][Full Text] [Related]
38. Dapsone acetylation by human liver arylamine N-acetyltransferases and interaction with antiopportunistic infection drugs.
Palamanda JR; Hickman D; Ward A; Sim E; Romkes-Sparks M; Unadkat JD
Drug Metab Dispos; 1995 Apr; 23(4):473-7. PubMed ID: 7600914
[TBL] [Abstract][Full Text] [Related]
39. Expression of serine protease inhibitors in epidermal keratinocytes is increased by calcium but not 1,25-dihydroxyvitamin D
Kobashi M; Morizane S; Sugimoto S; Sugihara S; Iwatsuki K
Br J Dermatol; 2017 Jun; 176(6):1525-1532. PubMed ID: 27797397
[TBL] [Abstract][Full Text] [Related]
40. Pathways of carbamazepine bioactivation in vitro: II. The role of human cytochrome P450 enzymes in the formation of 2-hydroxyiminostilbene.
Pearce RE; Uetrecht JP; Leeder JS
Drug Metab Dispos; 2005 Dec; 33(12):1819-26. PubMed ID: 16135660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
